RdRP-IN-4
RdRP-IN-4 (11q) is an orally bioavailable arylbenzohydrazide inhibitor targeting the PB1 subunit of influenza virus RdRp. It demonstrates potent in vitro activity against influenza A (H1N1) and B strains with EC50 values of 53 nM and 20 nM, respectively, and has shown significant antiviral efficacy in mouse infection models.
Product Specifications
Field of Research
Infectious Disease & Virology
Molecular Formula
C17H17Br2N3O2
Molecular Weight
455.14
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CWB90645-01 50 mg
5- (1-Phenyl-1H-pyrazol-4-yl) -1,3,4-oxadiazol-2-amine
Sign In for Pricing
View Details CWB90645-02 0.5 g
5- (1-Phenyl-1H-pyrazol-4-yl) -1,3,4-oxadiazol-2-amine
Sign In for Pricing
View Details 